BIOMAT Database Logo BIOMAT Database Logo

OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. 1994

D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Service de Néphrologie, Nantes University Hospital, France.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation.
June 1998, Transplantation proceedings,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients.
December 1995, Transplantation proceedings,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
October 1988, Transplantation proceedings,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Aggressive treatment of the first acute rejection episode using first-line anti-lymphocytic preparation reduces further acute rejection episodes after human kidney transplantation.
January 1998, Transplant international : official journal of the European Society for Organ Transplantation,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation.
April 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
September 2005, Transplantation proceedings,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Acute rejection episodes after kidney transplantation.
May 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Late acute rejection episodes after vascularized pancreas transplantation.
June 1998, Transplantation proceedings,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation.
February 1991, Transplantation proceedings,
D Cantarovich, and M Hourmant, and J Dantal, and M Giral, and J Paineau, and G Karam, and J P Soulillou
Analysis of incidence and pattern of acute rejection episodes after simultaneous pancreas and kidney transplantation.
January 1997, Transplantation proceedings,
Copied contents to your clipboard!